Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1424 of 5804
-
Can tighter blood pressure control shield hearts during breast cancer therapy?
Disease control Recruiting nowThe purpose of this study to find out whether an intensive approach to treating high blood pressure during breast cancer treatment is safe and more effective than standard blood pressure treatment at lowering blood pressure levels and the risk of cardiotoxicity in patients with c…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New cancer drug DB-1310 enters first human trials
Disease control Recruiting nowThis is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1310 in subjects with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a common blood pressure drug prevent radiation scarring in breast cancer patients?
Disease control OngoingThis study will evaluate the efficacy of losartan (LOS), an FDA-approved transforming growth factor beta-1 (TGF-β1) blocker, to decrease radiation induced fibrosis (RIF) in the breast and the lung of breast cancer patients, testing the hypothesis that Losartan will decrease RIF, …
Phase: PHASE2 • Sponsor: Shaw Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for Hard-to-Treat cancers: experimental drug DB-1311 enters human trials
Disease control Recruiting nowThis is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1311/BNT324 in subjects with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New inhaled therapy aims to slow lung transplant rejection
Disease control Recruiting nowThe goal of this clinical trial is to learn about the safety and effectiveness of LAM-001 in patients who have developed bronchiolitis obliterans syndrome (BOS), a form of chronic rejection, after lung transplantation. The main questions it aims to answer are: * Is LAM-001 safe…
Phase: PHASE2 • Sponsor: Steven Hays, MD • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New HIV combo shot shows promise in early trial
Disease control OngoingThe study aims at evaluating the efficacy of VH3810109, dosed in accordance with the dosing schedule as either intravenous (IV) infusion or subcutaneous (SC) infusion with recombinant hyaluronidase (rHuPH20), in combination with cabotegravir (CAB) intramuscular (IM) dosed in acco…
Phase: PHASE2 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug combo targets tough cancers with RAS mutation
Disease control OngoingTo evaluate the efficacy of naporafenib administered with trametinib in patients with rat sarcoma viral oncogene (RAS) Q61X solid tumors * To evaluate the safety and tolerability of naporafenib administered with trametinib in patients with RAS Q61X solid tumors * To characterize…
Phase: PHASE1 • Sponsor: Erasca, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New study tests bone tumor drug in chinese patients
Disease control OngoingThe study aims to evaluate the efficacy of XGEVA® in Chinese participants with giant cell tumor of bone (GCTB).
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New 12-step heart ablation method aims to keep irregular heartbeat away longer
Disease control CompletedWhile radiofrequency and cryoballoon ablation have shown high rates of pulmonary vein reconnection in patients undergoing repeat electrophysiological evaluation for AF recurrence, early evaluations demonstrated a remarkably high rate of durable PVI with pentaspline pulsed field a…
Sponsor: Daniel Rodríguez Muñoz • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for ITP patients: experimental drug aims to boost platelets
Disease control OngoingThe purpose of this study is to evaluate the therapeutic efficacy, safety and tolerability of ianalumab in adult patients with primary ITP previously treated with at least one corticosteroid and one TPO-RA.
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New combo therapy shows promise for Tough-to-Treat rheumatoid arthritis
Disease control CompletedThe purpose of this study is to evaluate the efficacy of combination therapy with nipocalimab and certolizumab compared to certolizumab monotherapy.
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can blood filtering beat long COVID fatigue?
Symptom relief CompletedThe complex clinical symptoms of post COVID syndrome, especially chronic fatigue, pose a major challenge to patients and to the health care system and are frequently refractory to therapeutic intervention. There is increasing evidence that a dysregulated post-viral immune respons…
Phase: NA • Sponsor: Hannover Medical School • Aim: Symptom relief
Last updated Jun 26, 2026 17:05 UTC
-
Canadian trial tests monkeypox drug in outpatients
Disease control TerminatedPLATINUM-CAN is a parallel collaborative trial linked with the sister trial PLATINUM led by Oxford University. PLATINUM-CAN is a multi-centre, randomized, placebo-controlled trial of Tecovirimat in non-hospitalized patients with presumptive or PCR confirmed monkeypox infection. T…
Phase: PHASE3 • Sponsor: Marina Klein • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could less radiation be better for anal cancer? new trial aims to find out
Disease control OngoingTo determine the efficacy of reduced elective nodal radiation in anal cancer patients undergoing chemoradiation in reducing toxicity compared to standard nodal irradiation.
Phase: PHASE2, PHASE3 • Sponsor: University of Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could ritalin sharpen your mind if you have epilepsy?
Symptom relief Recruiting nowMethylphenidate (MPH) is a stimulant, FDA-approved for the treatment of attention deficit hyperactivity disorder (ADHD). It is unknown, however, if stimulants would be of benefit for memory and thinking problems due to epilepsy. In this study, participants will be assigned random…
Phase: PHASE4 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New pill shows promise against tough cancers and brain tumors
Disease control Recruiting nowNBM-BMX is an orally available new chemical entity to inhibit histone deacetylases 8 (HDAC8) activity specifically, being developed as a potential anti-cancer therapeutic by NatureWise. This study aims to evaluate the safety, pharmacokinetics, and preliminary efficacy of NBM-BMX …
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Coffee made from wormwood plant tested against prostate cancer return
Disease control OngoingUntil now, clinicians have been challenged to improve the treatment of biochemically recurrent (BCR) prostate cancer in which prostatic specific antigen (PSA) rises without radiological or clinical progression years after localized treatment (radical prostatectomy or radiation th…
Phase: PHASE2 • Sponsor: Zin W Myint • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New gout drug ABP-671 shows promise in lowering uric acid
Disease control CompletedThis is a multicenter, randomized, double-blind, Phase 2b/3 study to evaluate the efficacy and safety of ABP-671. Part 1 of the study will compare the efficacy and safety of different doses and regimens of ABP-671 with placebo and allopurinol. Part 2 of the study will compare the…
Phase: PHASE2, PHASE3 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Which Pre-Transplant chemo works best for MDS/AML? new trial aims to find out
Disease control OngoingThis phase II trials studies the effect of treosulfan-based versus clofarabine-based conditioning regimens before donor hematopoietic stem cell transplant in treating patients with myelodysplastic syndromes or acute myeloid leukemia. Chemotherapy drugs, such as treosulfan, fludar…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:15 UTC
-
One-Hour nerve zaps could speed up injury recovery
Disease control Recruiting nowA novel temporary peripheral nerve stimulation system that delivers a single dose of electrical stimulation therapy for 1 hour will be evaluated for safety and effectiveness.
Phase: NA • Sponsor: Epineuron Technologies Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC